97283540 - ERZOFRI

Information

  • Trademark
  • 97283540
  • Serial Number
    97283540
  • Registration Number
    7167058
  • Filing Date
    February 24, 2022
    2 years ago
  • Registration Date
    September 19, 2023
    9 months ago
  • Transaction Date
    September 19, 2023
    9 months ago
  • Status Date
    September 19, 2023
    9 months ago
  • Published for Opposition Date
    July 04, 2023
    12 months ago
  • Location Date
    September 19, 2023
    9 months ago
  • Status Code
    700
  • Current Location
    PUBLICATION AND ISSUE SECTION
    Employee Name
    BURDECKI, ANNA C
  • Attorney Name
    Paulo A. de Almeida
    Law Office Assigned Location Code
    L80
  • Owners
Mark Drawing Code
4000
Mark Identification
ERZOFRI
Case File Statements
  • GS0051: Medicines for human purposes for the treatment of schizophrenia in adults; medicines for human purposes for the treatment of schizoaffective disorder in adults as mono therapy and as an adjunct to mood stabilizers or antidepressants; chemical preparations for pharmaceutical purposes, namely, for the treatment of schizophrenia in adults; chemical preparations for pharmaceutical purposes, namely, for treatment of schizoaffective disorder in adults as mono therapy and as an adjunct to mood stabilizers or antidepressants; Biochemical medicines for the treatment of schizophrenia in adults; Biochemical medicines for the treatment of schizoaffective disorder in adults as mono therapy and as an adjunct to mood stabilizers or antidepressants; pharmaceutical preparations for treatment of schizophrenia in adults; pharmaceutical preparations for treatment of schizoaffective disorder in adults as mono therapy and as an adjunct to mood stabilizers or antidepressants; chemico-pharmaceutical preparations for treatment of schizophrenia in adults; chemico-pharmaceutical preparations for treatment of schizoaffective disorder in adults as mono therapy and as an adjunct to mood stabilizers or antidepressants; Injectable pharmaceuticals for treatment of schizophrenia in adults; Injectable pharmaceuticals for treatment of schizoaffective disorder in adults as mono therapy and as an adjunct to mood stabilizers or antidepressants; antidepressants; dressings, medical
Case File Event Statements
  • 9/19/2023 - 9 months ago
    22 - NOTICE OF REGISTRATION CONFIRMATION EMAILED Type: NRCC
  • 9/19/2023 - 9 months ago
    21 - REGISTERED-PRINCIPAL REGISTER Type: R.PR
  • 7/4/2023 - 12 months ago
    20 - OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED Type: NPUB
  • 7/4/2023 - 12 months ago
    19 - PUBLISHED FOR OPPOSITION Type: PUBO
  • 6/14/2023 - a year ago
    18 - NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED Type: NONP
  • 5/31/2023 - a year ago
    17 - LAW OFFICE PUBLICATION REVIEW COMPLETED Type: PREV
  • 5/24/2023 - a year ago
    16 - APPROVED FOR PUB - PRINCIPAL REGISTER Type: CNSA
  • 4/14/2023 - a year ago
    15 - TEAS/EMAIL CORRESPONDENCE ENTERED Type: TEME
  • 4/14/2023 - a year ago
    14 - CORRESPONDENCE RECEIVED IN LAW OFFICE Type: CRFA
  • 4/14/2023 - a year ago
    13 - APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED Type: CHAN
  • 4/14/2023 - a year ago
    12 - ASSIGNED TO LIE Type: ALIE
  • 2/15/2023 - a year ago
    11 - AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP Type: ASGN
  • 1/18/2023 - a year ago
    10 - TEAS RESPONSE TO SUSPENSION INQUIRY RECEIVED Type: ERSI
  • 1/6/2023 - a year ago
    9 - TEAS CHANGE OF CORRESPONDENCE RECEIVED Type: TCCA
  • 1/6/2023 - a year ago
    8 - ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED Type: ARAA
  • 1/6/2023 - a year ago
    7 - TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED Type: REAP
  • 12/17/2022 - a year ago
    6 - NOTIFICATION OF LETTER OF SUSPENSION E-MAILED Type: GNS3
  • 12/17/2022 - a year ago
    5 - LETTER OF SUSPENSION E-MAILED Type: GNSL
  • 12/17/2022 - a year ago
    4 - SUSPENSION LETTER WRITTEN Type: CNSL
  • 12/7/2022 - a year ago
    3 - ASSIGNED TO EXAMINER Type: DOCK
  • 3/2/2022 - 2 years ago
    2 - NEW APPLICATION OFFICE SUPPLIED DATA ENTERED Type: NWOS
  • 2/28/2022 - 2 years ago
    1 - NEW APPLICATION ENTERED Type: NWAP